These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 383614)

  • 21. C1q enhances the phagocytosis of Cryptococcus neoformans blastospores by human monocytes.
    Bobak DA; Washburn RG; Frank MM
    J Immunol; 1988 Jul; 141(2):592-7. PubMed ID: 3290342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phagocytosis of Cryptococcus neoformans by normal and thioglycolate-activated macrophages.
    Swenson FJ; Kozel TR
    Infect Immun; 1978 Sep; 21(3):714-20. PubMed ID: 361575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of serum factors in the phagocytosis of weakly or heavily encapsulated Cryptococcus neoformans strains by guinea pig peripheral blood leukocytes.
    Ikeda R; Shinoda T; Kagaya K; Fukazawa Y
    Microbiol Immunol; 1984; 28(1):51-61. PubMed ID: 6374392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody action after phagocytosis promotes Cryptococcus neoformans and Cryptococcus gattii macrophage exocytosis with biofilm-like microcolony formation.
    Alvarez M; Saylor C; Casadevall A
    Cell Microbiol; 2008 Aug; 10(8):1622-33. PubMed ID: 18384661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phagocytosis and killing of Cryptococcus neoformans by rat alveolar macrophages in the absence of serum.
    Bolaños B; Mitchell TG
    J Leukoc Biol; 1989 Dec; 46(6):521-8. PubMed ID: 2681492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Occurrences, immunoglobulin classes, and biological activities of antibodies in normal human serum that are reactive with Cryptococcus neoformans glucuronoxylomannan.
    Houpt DC; Pfrommer GS; Young BJ; Larson TA; Kozel TR
    Infect Immun; 1994 Jul; 62(7):2857-64. PubMed ID: 8005676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibodies to Cryptococcus neoformans glucuronoxylomannan enhance antifungal activity of murine macrophages.
    Mukherjee S; Lee SC; Casadevall A
    Infect Immun; 1995 Feb; 63(2):573-9. PubMed ID: 7822024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth inhibition of Cryptococcus neoformans by cultured human monocytes: role of the capsule, opsonins, the culture surface, and cytokines.
    Levitz SM; Farrell TP
    Infect Immun; 1990 May; 58(5):1201-9. PubMed ID: 2182538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study of Fc gamma murine macrophage receptors (Fc gamma R) in the internalization of Histoplasma capsulatum yeasts.
    Taylor ML; Rico B; Goodsaid F
    Arch Med Res; 1995; 26(2):179-84. PubMed ID: 7620285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholesterol and sphingomyelin are critical for Fcγ receptor-mediated phagocytosis of Cryptococcus neoformans by macrophages.
    Bryan AM; You JK; Li G; Kim J; Singh A; Morstein J; Trauner D; Pereira de Sá N; Normile TG; Farnoud AM; London E; Del Poeta M
    J Biol Chem; 2021 Dec; 297(6):101411. PubMed ID: 34793834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Opsonization of Cryptococcus neoformans by human anticryptococcal glucuronoxylomannan antibodies.
    Zhong Z; Pirofski LA
    Infect Immun; 1996 Sep; 64(9):3446-50. PubMed ID: 8751883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Binding of Cryptococcus neoformans by human cultured macrophages. Requirements for multiple complement receptors and actin.
    Levitz SM; Tabuni A
    J Clin Invest; 1991 Feb; 87(2):528-35. PubMed ID: 1991837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phagocytosis of nonopsonized Cryptococcus neoformans by swine microglia involves CD14 receptors.
    Lipovsky MM; Gekker G; Anderson WR; Molitor TW; Peterson PK; Hoepelman AI
    Clin Immunol Immunopathol; 1997 Aug; 84(2):208-11. PubMed ID: 9245554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody-dependent natural killer cell-mediated growth inhibition of Cryptococcus neoformans.
    Nabavi N; Murphy JW
    Infect Immun; 1986 Feb; 51(2):556-62. PubMed ID: 3510982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fc- and complement-receptor activation stimulates cell cycle progression of macrophage cells from G1 to S.
    Luo Y; Tucker SC; Casadevall A
    J Immunol; 2005 Jun; 174(11):7226-33. PubMed ID: 15905568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on the mechanism of phagocytosis. I. Requirements for circumferential attachment of particle-bound ligands to specific receptors on the macrophage plasma membrane.
    Griffin FM; Griffin JA; Leider JE; Silverstein SC
    J Exp Med; 1975 Nov; 142(5):1263-82. PubMed ID: 1194852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of FcγR-mediated phagocytosis by IVIg is independent of IgG-Fc sialylation and FcγRIIb in human macrophages.
    Nagelkerke SQ; Dekkers G; Kustiawan I; van de Bovenkamp FS; Geissler J; Plomp R; Wuhrer M; Vidarsson G; Rispens T; van den Berg TK; Kuijpers TW
    Blood; 2014 Dec; 124(25):3709-18. PubMed ID: 25352126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dissociation of a hydrophobic surface from phagocytosis of encapsulated and non-encapsulated cryptococcus neoformans.
    Kozel TR
    Infect Immun; 1983 Mar; 39(3):1214-9. PubMed ID: 6341232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strain variation in phagocytosis of Cryptococcus neoformans: dissociation of susceptibility to phagocytosis from activation and binding of opsonic fragments of C3.
    Kozel TR; Pfrommer GS; Guerlain AS; Highison BA; Highison GJ
    Infect Immun; 1988 Nov; 56(11):2794-800. PubMed ID: 3049374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of IgG preparations by a turbidimetric assay of opsonizing capacity.
    Német K; Medgyesi GA
    Immunol Lett; 2000 Jul; 73(1):71-4. PubMed ID: 10963814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.